Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms,… Read more
Labiana Health S.A. (LAB) - Total Assets
Latest total assets as of December 2022: €60.78 Million EUR
Based on the latest financial reports, Labiana Health S.A. (LAB) holds total assets worth €60.78 Million EUR as of December 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Labiana Health S.A. - Total Assets Trend (2022–2022)
This chart illustrates how Labiana Health S.A.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Labiana Health S.A. - Asset Composition Analysis
Current Asset Composition (December 2022)
Labiana Health S.A.'s total assets of €60.78 Million consist of 47.3% current assets and 52.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €2.52 Million | 0.0% |
| Accounts Receivable | €8.78 Million | 14.4% |
| Inventory | €13.83 Million | 22.8% |
| Property, Plant & Equipment | €20.64 Million | 34.0% |
| Intangible Assets | €9.04 Million | 14.9% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2022–2022)
This chart illustrates how Labiana Health S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Asset Diversification: The largest asset category is property, plant & equipment at 34.0% of total assets.
Labiana Health S.A. Competitors by Total Assets
Key competitors of Labiana Health S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Newbury Pharmaceuticals AB
ST:NEWBRY
|
Sweden | Skr76.58 Million |
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Cronos Group Inc
NASDAQ:CRON
|
USA | $1.20 Billion |
|
BioNxt Solutions Inc.
OTCQB:BNXTF
|
USA | $1.23 Million |
|
Evoke Pharma Inc
NASDAQ:EVOK
|
USA | $15.65 Million |
|
Caring Brands, Inc. Common Stock
NASDAQ:CABR
|
USA | $3.17 Million |
|
Medical Marijuana I
PINK:MJNA
|
USA | $67.97 Million |
|
EVIO Inc
PINK:EVIO
|
USA | $953.00K |
Labiana Health S.A. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Labiana Health S.A. generates 0.95x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Labiana Health S.A. is currently not profitable relative to its asset base.
Labiana Health S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.82 | 1.06 | - |
| Quick Ratio | 0.43 | 0.59 | - |
| Cash Ratio | 0.07 | 0.16 | - |
| Working Capital | €-6.31 Million | € 2.08 Million | - |
Labiana Health S.A. - Advanced Valuation Insights
This section examines the relationship between Labiana Health S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.27 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | €60.78 Million |
| Market Capitalization | $11.19 Million USD |
Valuation Analysis
Below Book Valuation: The market values Labiana Health S.A.'s assets below their book value (0.18 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Labiana Health S.A.'s assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Labiana Health S.A. (2022–2022)
The table below shows the annual total assets of Labiana Health S.A. from 2022 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | €60.78 Million | -- |